Neurim Pharmaceuticals Ltd.
- Biotech or pharma, therapeutic R&D
Neurim Pharmaceuticals Ltd. has a strong track record in drug development and commercialization, with products like Circadin and Slenyto approved and used by millions in 40+ countries.
We’re looking for a strategic partner with expertise in pediatric neurology and/or psychiatry to out-license our innovative Rx product, Slenyto.
Slenyto is approved pharmacotherapy for treating insomnia in children and adolescents (2-18) with autism spectrum disorder (ASD), Smith-Magenis Syndrome (SMS), Neurogenetic Disorders, and ADHD.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}